XML 46 R37.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Reporting [Abstract] |
Reportable Segment Information | Reportable segment information was as follows:
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
(DOLLARS IN MILLIONS) | 2022 |  | 2021 |  | 2022 |  | 2021
Net sales: |  |  |  |  |  |  |
Nourish | $ | 1,703 |  |  | $ | 1,662 |  |  | $ | 5,252 |  |  | $ | 4,638 |
Health & Biosciences | 512 |  |  | 618 |  |  | 1,838 |  |  | 1,683 |
Scent | 591 |  |  | 580 |  |  | 1,756 |  |  | 1,699 |
Pharma Solutions | 257 |  |  | 211 |  |  | 750 |  |  | 605 |
Consolidated | $ | 3,063 |  |  | $ | 3,071 |  |  | $ | 9,596 |  |  | $ | 8,625 |
Segment Adjusted Operating EBITDA: |  |  |  |  |  |  |
Nourish | $ | 287 |  |  | $ | 327 |  |  | $ | 981 |  |  | $ | 921 |
Health & Biosciences | 137 |  |  | 151 |  |  | 513 |  |  | 469 |
Scent | 119 |  |  | 130 |  |  | 328 |  |  | 375 |
Pharma Solutions | 69 |  |  | 40 |  |  | 192 |  |  | 131 |
Total | 612 |  |  | 648 |  |  | 2,014 |  |  | 1,896 |
Depreciation & Amortization | (293) |  |  | (297) |  |  | (897) |  |  | (861) |
Interest Expense | (83) |  |  | (74) |  |  | (232) |  |  | (216) |
Other Income, net | 33 |  |  | 26 |  |  | 43 |  |  | 44 |
Acquisition Related Costs (a) | (1) |  |  | — |  |  | (2) |  |  | — |
Restructuring and Other Charges | 4 |  |  | (6) |  |  | (5) |  |  | (34) |
Gains on sales of fixed assets | — |  |  | 1 |  |  | 2 |  |  | 1 |
Impairment of Goodwill (b) | (2,250) |  |  | — |  |  | (2,250) |  |  | — |
Impairment of Long-Lived Assets (c) | — |  |  | — |  |  | (120) |  |  | — |
Shareholder Activism Related Costs (d) | — |  |  | — |  |  | (3) |  |  | (7) |
Business Divestiture Costs (e) | (31) |  |  | (16) |  |  | (91) |  |  | (21) |
Employee Separation Costs (f) | — |  |  | (22) |  |  | (4) |  |  | (28) |
Global Shared Services Implementation Costs (g) | (1) |  |  | — |  |  | (1) |  |  | — |
Frutarom Acquisition Related Costs (h) | — |  |  | — |  |  | (1) |  |  | — |
N&B Inventory Step-Up Costs | — |  |  | 14 |  |  | — |  |  | (363) |
N&B Transaction Related Costs (i) | — |  |  | — |  |  | — |  |  | (91) |
Integration Related Costs (j) | (25) |  |  | (24) |  |  | (73) |  |  | (80) |
(Loss) Income Before Taxes | $ | (2,035) |  |  | $ | 250 |  |  | $ | (1,620) |  |  | $ | 240 |
_______________________
(a) | Represents costs related to the acquisition of Health Wright Products, primarily consulting and legal fees.
(b) | Represents costs related to the impairment of goodwill in the Health & Biosciences reporting unit.
(c) | Represents costs related to the impairment of intangible and fixed assets of an asset group that operates primarily in Russia.
(d) | Represents shareholder activist related costs, primarily professional fees.
(e) | Represents costs related to the Company's planned sales of businesses, primarily legal and professional fees.
(f) | Represents costs related to severance, including accelerated stock compensation expense, for certain employees and executives who have been separated or will separate from the Company.
(g) | Represents costs related to the Company's efforts of restructuring the Global Shared Services Centers, primarily consulting fees.
(h) | Represents transaction-related costs and expenses related to the acquisition of Frutarom.
(i) | Represents transaction costs and expenses related to the transaction with N&B, primarily legal and professional fees.
(j) | Represents costs related to integration activities since 2018, primarily for Frutarom and N&B. For 2022, represents costs primarily related to external consulting fees and internal integration costs, including salaries of individuals who are fully dedicated to integration efforts. For 2021, represents costs primarily related to performance stock awards and consulting fees for advisory services.
Net Sales by Destination of Product Delivery | Net sales, which are attributed to individual regions based upon the destination of product delivery, were as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(DOLLARS IN MILLIONS) | 2022 |  | 2021 |  | 2022 |  | 2021
Europe, Africa and Middle East | $ | 1,030 |  |  | $ | 1,084 |  |  | $ | 3,258 |  |  | $ | 3,041 |
Greater Asia | 701 |  |  | 696 |  |  | 2,200 |  |  | 1,990 |
North America | 939 |  |  | 925 |  |  | 3,006 |  |  | 2,608 |
Latin America | 393 |  |  | 366 |  |  | 1,132 |  |  | 986 |
Consolidated | $ | 3,063 |  |  | $ | 3,071 |  |  | $ | 9,596 |  |  | $ | 8,625 |
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(DOLLARS IN MILLIONS) | 2022 |  | 2021 |  | 2022 |  | 2021
Net sales related to the U.S. | $ | 920 |  |  | $ | 860 |  |  | $ | 2,799 |  |  | $ | 2,390 |
Net sales attributed to all foreign countries | 2,143 |  |  | 2,211 |  |  | 6,797 |  |  | 6,235 |

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration